Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05253677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05253677 · ClinicalTrials.gov record · last posted 2026-01-21

Precise Procedural and PCI Plan (P4)

Study acronym: P4
StatusActive, Not Recruiting
PhaseNot applicable
Started2022-04-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 21, 2026 (before its estimated August 4, 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Computed tomography (CT) has become an established tool in the diagnostic workup of patients with suspected coronary artery disease (CAD). The availability of coronary CT angiography (CCTA) before the invasive procedure allows stratifying case complexity and can be used to improve patient selection for PCI, to plan and guide therapeutic interventions. Beyond the diagnostic and therapeutic phase, it helps to better organize the catheterization laboratory workflow. The P4 study is an investigator-initiated, multicenter, randomized study with a non-inferiority design of patients with an indication for PCI aiming at comparing clinical outcomes between two imaging strategies to guide PCI, being coronary CT-guided PCI strategy (investigational technology) and IVUS-guided PCI strategy (comparator). After identifying the presence of a significant coronary stenosis, the patient will be randomized either to CT- or IVUS-guided PCI groups. Both CT and IVUS-guided PCI will be performed following the P4 trial protocol. When the procedure is completed, post-PCI FFR will be measured. All patients will be followed in hospital, at 30 days (±15 days), 12 months (±1 month) and yearly until 5 year.

Amendment record 4 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 4 times since 2022-02-11; most recent amendment 2026-01-19. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-01-19
Status change RecruitingActive, Not Recruitingv4
2022-05-30
Status change Not Yet RecruitingRecruitingv1
Trial Details
NCT Number NCT05253677
Lead Sponsor CoreAalst BV
Conditions Coronary Artery Disease
Enrollment 1,090 participants
Start Date 2022-04-01
Primary Completion 2026-08-04 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-21